Condition: Chronic Kidney Diseases · Sponsor: The George Institute
CAPTIVATE is an international, multi-centre, Phase III, adaptive, platform, randomised controlled trial in people with chronic kidney disease (CKD). CAPTIVATE aims to find the best treatment, or combination of treatments, that slow the progression of CKD so that fewer people develop kidney failure. CAPTIVATE provides a research platform that allows many treatment-related questions to be answered within a common trial set-up.
This description comes directly from the study's public registry record.
Enmoore Lin · 61 2 8052 4511 · captivate@georgeinstitute.org.au
Always discuss trial participation with your own doctor first.
| The Canberra Hospital | Garran, Australian Capital Territory, Australia | Recruiting |
| Nepean Blue Mountains Local Health District | Kingswood, New South Wales, Australia | Recruiting |
| St George Hospital | Kogarah, New South Wales, Australia | Recruiting |
| John Hunter Hospital | New Lambton Heights, New South Wales, Australia | Recruiting |
| Westmead Hospital | Westmead, New South Wales, Australia | Recruiting |
| Sunshine Coast Hospital and Health Service | Birtinya, Queensland, Australia | Recruiting |
| Townsville University Hospital | Douglas, Queensland, Australia | Recruiting |
| West Moreton Hospital & Health Service | Ipswich, Queensland, Australia | Recruiting |
| Gold Coast Hospital and Health Service | Southport, Queensland, Australia | Recruiting |
| Royal Adelaide | Adelaide, South Australia, Australia | Recruiting |
| Lyell McEwin Hospital | Elizabeth Vale, South Australia, Australia | Recruiting |
| Austin Health | Heidelberg, Victoria, Australia | Recruiting |
+ 31 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.